Thought Leadership Drug Discovery Targets & Screening |

Executive Interview with Peter Sullivan, MyxoTech

On-Demand
July 11, 2025
|
00:00 UK Time
|
Event lasts 17m
Peter Sullivan

Peter Sullivan

Chief Executive Officer

MyxoTech

Format: 17 minute interview

Related posts
Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Rick Ewing Rapafusyn Pharmaceuticals
Zoran Rankovic St. Jude Children’s Research Hospital
Kyle Eastman Halda Therpeutics
Danette Daniels Foghorn Therapeutics
Drug Discovery
Jan, 2026
Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Stefan Schiesser AstraZeneca
Drug Discovery
Nov, 2025
Designing Next-Gen Biomaterials: Peptide Hydrogels in 3D Culture & Regenerative Platforms

Designing Next-Gen Biomaterials: Peptide Hydrogels in 3D Culture & Regenerative Platforms

Aline Miller University of Manchester
Vasiliki Kalodimou European University-Cyprus – Frankfurt Branch
Maryna Panamarova Wellcome Sanger Institute
Andy Wiranata Wijaya Nestlé
Drug Discovery
Nov, 2025
Unlocking the Brain- Innovations in CNS Drug Discovery and Neurodegenerative Treatment

Unlocking the Brain- Innovations in CNS Drug Discovery and Neurodegenerative Treatment

Emma Mead Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford
S Moein Moghimi School of Pharmacy, Newcastle University, UK
Shadi Farhangrazi S. M. Discovery Group (SMDG)
Ralph Minter Alchemab
Drug Discovery
Sep, 2025
Executive Interview with Joshua Baughman, Bristol Myers Squibb

Executive Interview with Joshua Baughman, Bristol Myers Squibb

Joshua Baughman Bristol Myers Squibb
Drug Discovery
Oct, 2025
Upcoming events
02
Mar
Advancing Formulation Development

Online

This tech showcase will spotlight cutting-edge approaches to enhancing solubility and bioavailability, including predictive modeling, data-driven formulation design, and innovative delivery systems. Attendees will see these technologies in action and engage in a live discussion with industry experts to uncover real-world applications and address formulation challenges.

18
Mar
Drug Formulation & Delivery: Oral GLP‑1 Systems

Online

Join Andreas Bernkop-Schnurch to explore "Drug Formulation & Delivery: Oral GLP‑1 Systems".

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.